Led by scientists at the UNC School of Medicine, the five-year multi-lab effort lays the groundwork for developing treatments.
Past winners include six scientists who went on to win the Nobel Prize
Researchers at the Carolina Institute for Developmental Disabilities tracking age-related issues of autism identified an increased risk of Parkinson’s disease in this high-impact paper.
Richard Loeser, MD, takes a new look at the role of reactive oxygen species or "free radicals" in arthritis, and provides data needed to design new therapies for this debilitating disease.
Proof-of-concept study provides roadmap for future research into possible associations between brain volume measures and known genetic risk factors.
UNC Lineberger joins nation’s cancer centers in endorsement of HPV vaccination for cancer prevention
Joint statement urges parents, young adults and physicians to act to increase vaccination rates
UNC-Chapel Hill is one of nine sites across the nation participating in this national, first-of-its-kind, registry.
Researchers at the University of North Carolina and The Children’s Hospital of Philadelphia treated factor VII deficient dogs with normal copies of genes; three years later the dogs remain healthy with no side effects.
The goal of the award is to bring mothers and providers together to address unmet health care needs during the “fourth trimester.”
The research collaborators, who have made scientific breakthroughs in the fields of chronic pain, autism, and Angelman syndrome, will serve as director and associate director, replacing longtime director William Snider.
New research findings from the UNC School of Medicine add further clarity to a question that has polarized the cystic fibrosis research community.
In a study published in the journal Annals of Surgery, researchers report that breast cancer patients surveyed about their knowledge of breast reconstruction were only moderately informed about the procedure, and their knowledge of complications was low.
In the journal Cell Reports, UNC Lineberger researchers report that when they removed Dicer from preclinical models of medulloblastoma, a common type of brain cancer in children, they found high levels of DNA damage in the cancer cells, leading to the cells’ death.
A team of investigators supported in part by a $50,000 CTSA-supported UNC /Duke Collaborative Pilot Program has published results of their research into using CRISPR to treat an adult mouse model of Duchenne muscular dystrophy using a virus to deliver the gene-editing system. This marks the first time that the CRISPR technique has successfully treated a genetic disease inside a fully developed living mammal with a strategy that has the potential to be translated to human therapy.
Despite Gender Disparity in Compensation, Increasing Number of Women Entering the Field, According to New Study Published in The Journal of Urology®
For the first time, scientists pin down the structure of toxic clumps of a protein associated with a large number of ALS cases, opening new avenues in the pursuit of drugs to stem the disease.
Biomedical engineering student Scott Vu creates a new tool that prompts bacteria to make proteins for various biotech industrial uses.
About 90 percent of us live with HSV inside brain cells. Under stress, the virus leaves neurons and can cause cold sores, recurrent eye infection, and in rare cases encephalitis.
This week, Aziz Sancar is in Sweden to accept the Nobel Prize in Chemistry. Life since the announcement that he won has been a little hectic.
An Internet-based system for symptom collection benefited patients while giving them a clearer voice in their own care.